Pemtumomab
From Wikipedia, the free encyclopedia
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Source | Mouse |
| Target | MUC1 |
| Clinical data | |
| Trade names | Theragyn |
| Routes of administration | Intraperitoneal |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
  (what is this?) (verify) | |
Pemtumomab (trade name Theragyn) is a mouse monoclonal antibody used to treat cancer. The substance has affinity to various types of cancer, like ovarian cancer and peritoneal cancer, via the polymorphic epithelial mucin (PEM or MUC-1) and delivers the radioisotope Yttrium-90 into the tumour.[1] As of 2009[update], it is undergoing Phase III clinical trials.[2]
It has been granted orphan drug status in Europe.[3]
